Exchange Traded Concepts’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.1M Buy
1,293,117
+590,726
+84% +$15.5M 0.14% 136
2026
Q1
$19.7M Sell
702,391
-399,587
-36% -$10.6M 0.14% 160
2025
Q4
$27.4M Sell
1,101,978
-60,810
-5% -$1.53M 0.21% 94
2025
Q3
$29.6M Sell
1,162,788
-37,776
-3% -$932K 0.25% 79
2025
Q2
$29.1M Buy
1,200,564
+607,732
+103% +$14.2M 0.36% 61
2025
Q1
$15M Buy
592,832
+516,582
+677% +$13.5M 0.26% 82
2024
Q4
$2.02M Buy
76,250
+7,072
+10% +$192K 0.04% 371
2024
Q3
$2M Buy
69,178
+37,293
+117% +$1.09M 0.05% 333
2024
Q2
$892K Buy
31,885
+29,513
+1,244% +$813K 0.02% 473
2024
Q1
$65.8K Sell
2,372
-866
-27% -$24K ﹤0.01% 942
2023
Q4
$93.2K Buy
3,238
+2,883
+812% +$87.2K ﹤0.01% 893
2023
Q3
$11.8K Sell
355
-83,852
-100% -$2.97M ﹤0.01% 1152
2023
Q2
$3.09M Sell
84,207
-267,328
-76% -$10.4M 0.08% 211
2023
Q1
$14.3M Buy
351,535
+83,287
+31% +$3.6M 0.39% 53
2022
Q4
$13.7M Buy
268,248
+7,869
+3% +$377K 0.39% 48
2022
Q3
$11.4M Sell
260,379
-192,467
-43% -$9.35M 0.37% 30
2022
Q2
$23.7M Sell
452,846
-37,290
-8% -$1.9M 0.69% 16
2022
Q1
$25.4M Buy
490,136
+133,726
+38% +$6.94M 0.51% 32
2021
Q4
$21M Sell
356,410
-85,104
-19% -$4.22M 0.41% 38
2021
Q3
$19M Buy
441,514
+163,044
+59% +$7.22M 0.48% 24
2021
Q2
$10.9M Sell
278,470
-587
-0.2% -$22.8K 0.35% 50
2021
Q1
$10.1M Buy
279,057
+46,558
+20% +$1.65M 0.38% 44
2020
Q4
$8.56M Sell
232,499
-128,989
-36% -$4.73M 0.4% 40
2020
Q3
$12.6M Buy
361,488
+108,111
+43% +$3.79M 0.71% 23
2020
Q2
$7.86M Buy
+253,377
New +$8.61M 1.3% 11
2020
Q1
Sell
-50,868
Closed -$1.89M 573
2019
Q4
$1.89M Buy
+50,868
New +$1.81M 0.4% 41

Other funds holding PFE

Exchange Traded Concepts's PFE Position: Q2 2026 in Review

Exchange Traded Concepts increased its Pfizer (PFE) stake by 84% in Q2 2026, buying an estimated $15.5M and bringing the position to 1,293,117 shares worth $31.1M. The position accounts for 0.14% of the portfolio, ranked #136.

Exchange Traded Concepts first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Exchange Traded Concepts held 1,293,117 shares of Pfizer worth $31.1M as of Q2 2026.
  • Exchange Traded Concepts bought 590,726 Pfizer shares in Q2 2026, an estimated $15.5M.
  • Pfizer made up 0.14% of Exchange Traded Concepts's portfolio in Q2 2026, its #136 holding.
  • Exchange Traded Concepts first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.